1. Market Research
  2. > Biotechnology
  3. > Genomics Proteomics and Enabling Technology Market Trends
Biomarkers: Technologies and Global Markets

Biomarkers: Technologies and Global Markets

  • August 2018
  • 171 pages
  • ID: 488647
  • Format: PDF
  • By BCC Research

Summary

Table of Contents

Report Scope:
Current and projected biomarker market forecasts for the forecast period 2018 to 2023 are discussed. Products approved in the last three years by the U.S. Food and Drug Administration and products expected to be approved within the forecast period are projected. Due to the timing of this report, 2018 figures are estimated except where actual results have been reported.

This report includes an analysis of the leading and emerging competitors in the current worldwide biomarkers market.Profiles of manufacturers of leading products as well as biotechnology companies with novel products in development are analyzed to define specific product strategies that were employed.

This report also assesses companies poised to introduce products during the forecast period and discusses how these introductions will change the face of the competitive environment.The competitive environment is examined with a special focus on how new products and technologies are influencing the current standard of care.

Detailed profiles of the current market leaders, as well as companies with innovative products poised to advance within forecast period, are discussed.

In this report, market size and forecasts by segment, type, therapeutic area and geography from 2018 through 2023 have been provided.The study is arranged to offer an overview of the biomarkers market accompanied by product, company, geographic region or country.

Virtually the entire globe is covered to include prevalent data for each disease subsegment.The report encompasses the use of major types of biomarkers for clinical and research applications.

In addition, major applications that are being commercialized and developed by a wide range of companies, especially for drug discovery and development processes, are also considered. The application of biomarkers in the field of diagnostics and therapeutics for major indications such as cancer, immunological disorders, neurological disorders and others are also discussed.

Excluded from this report are over-the-counter (OTC) medications and other consumables that do not require a physician’s prescription.

Sales figures are reported in U.S. dollars and in each case reflect currency fluctuations within the performance of revenue change. Revenue figures do not account for variation in local currencies.

All market share data are presented on a global basis unless specifically noted.

Report Includes:
- 70 data tables and 42 additional tables
- Industry analysis of the global biomarkers market
- Country specific data and analysis for United States, Canada, Mexico, France, Germany, U.K., China, India, Japan, Middle East and Africa
- Characterization and quantification of the market potential for biomarkers by segment, product type, therapeutic area and geographical region
- Encompassing details of major types of biomarkers and their use in clinical and research applications
- Examination of regional market dynamics with a focus on regulatory development, key technology updates and major drivers impacting the global market
- Assessment of the leading biotechnology companies poised to introduce products during the forecast period, and their impact on the face of the competitive environment
- Detailed profiles of the leading biomarkers’ manufacturers, including Abbott Laboratories, Bayer Group, Bristol-Myers Squibb, Eli Lilly and Co., GlaxoSmithKline and Novartis AG

Report Scope:
Current and projected biomarker market forecasts for the forecast period 2018 to 2023 are discussed. Products approved in the last three years by the U.S. Food and Drug Administration and products expected to be approved within the forecast period are projected. Due to the timing of this report, 2018 figures are estimated except where actual results have been reported.

This report includes an analysis of the leading and emerging competitors in the current worldwide biomarkers market.Profiles of manufacturers of leading products as well as biotechnology companies with novel products in development are analyzed to define specific product strategies that were employed.

This report also assesses companies poised to introduce products during the forecast period and discusses how these introductions will change the face of the competitive environment.The competitive environment is examined with a special focus on how new products and technologies are influencing the current standard of care.

Detailed profiles of the current market leaders, as well as companies with innovative products poised to advance within forecast period, are discussed.

In this report, market size and forecasts by segment, type, therapeutic area and geography from 2018 through 2023 have been provided.The study is arranged to offer an overview of the biomarkers market accompanied by product, company, geographic region or country.

Virtually the entire globe is covered to include prevalent data for each disease subsegment.The report encompasses the use of major types of biomarkers for clinical and research applications.

In addition, major applications that are being commercialized and developed by a wide range of companies, especially for drug discovery and development processes, are also considered. The application of biomarkers in the field of diagnostics and therapeutics for major indications such as cancer, immunological disorders, neurological disorders and others are also discussed.

Excluded from this report are over-the-counter (OTC) medications and other consumables that do not require a physician’s prescription.

Sales figures are reported in U.S. dollars and in each case reflect currency fluctuations within the performance of revenue change. Revenue figures do not account for variation in local currencies.

All market share data are presented on a global basis unless specifically noted.

Report Includes:
- 70 data tables and 42 additional tables
- Industry analysis of the global biomarkers market
- Country specific data and analysis for United States, Canada, Mexico, France, Germany, U.K., China, India, Japan, Middle East and Africa
- Characterization and quantification of the market potential for biomarkers by segment, product type, therapeutic area and geographical region
- Encompassing details of major types of biomarkers and their use in clinical and research applications
- Examination of regional market dynamics with a focus on regulatory development, key technology updates and major drivers impacting the global market
- Assessment of the leading biotechnology companies poised to introduce products during the forecast period, and their impact on the face of the competitive environment
- Detailed profiles of the leading biomarkers’ manufacturers, including Abbott Laboratories, Bayer Group, Bristol-Myers Squibb, Eli Lilly and Co., GlaxoSmithKline and Novartis AG

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Biomarkers Market Size, Outlook and Growth Opportunities, 2019- 2025

Biomarkers Market Size, Outlook and Growth Opportunities, 2019- 2025

  • $ 4580
  • June 2019

Biomarkers Market Size, Outlook and Growth Opportunities, 2019- 2025Global Biomarkers Market Size, Outlook and Growth Opportunities to 2025: By Type (Safety, Efficacy, and Validation), By Application (Diagnostic, ...

Cancer Biomarker Market Size, Outlook and Growth Opportunities, 2019- 2025

Cancer Biomarker Market Size, Outlook and Growth Opportunities, 2019- 2025

  • $ 4580
  • June 2019

Cancer Biomarker Market Size, Outlook and Growth Opportunities, 2019- 2025Global Cancer Biomarker Market Size, Outlook and Growth Opportunities to 2025: By Type (Genetic Biomarkers, Protein Biomarkers, ...

NASH Biomarkers (Non alcoholic Steatohepatitis) Market Size, Outlook and Growth Opportunities, 2019- 2025

NASH Biomarkers (Non alcoholic Steatohepatitis) Market Size, Outlook and Growth Opportunities, 2019- 2025

  • $ 4580
  • June 2019

NASH Biomarkers (Non alcoholic Steatohepatitis) Market Size, Outlook and Growth Opportunities, 2019- 2025Global NASH Biomarkers (Non alcoholic Steatohepatitis) Market size, Outlook and Opportunities 2019- ...


ref:plp2018

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on